| Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells JA Fraietta, CL Nobles, MA Sammons, S Lundh, SA Carty, TJ Reich, ... Nature 558 (7709), 307-312, 2018 | 759 | 2018 |
| Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes MH Gee, A Han, SM Lofgren, JF Beausang, JL Mendoza, ME Birnbaum, ... Cell 172 (3), 549-563. e16, 2018 | 287 | 2018 |
| Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide-MHC binding LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ... Cell 174 (3), 672-687. e27, 2018 | 275 | 2018 |
| Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity JJ Adams, S Narayanan, ME Birnbaum, SS Sidhu, SJ Blevins, MH Gee, ... Nature immunology 17 (1), 87-94, 2016 | 134 | 2016 |
| T cell receptor cross-reactivity expanded by dramatic peptide–MHC adaptability TP Riley, LM Hellman, MH Gee, JL Mendoza, JA Alonso, KC Foley, ... Nature chemical biology 14 (10), 934-942, 2018 | 90 | 2018 |
| Identification of a functional docking site in the Rpn1 LRR domain for the UBA-UBL domain protein Ddi1 TA Gomez, N Kolawa, M Gee, MJ Sweredoski, RJ Deshaies BMC biology 9 (1), 1-15, 2011 | 89 | 2011 |
| Tuning T cell receptor sensitivity through catch bond engineering X Zhao, EM Kolawole, W Chan, Y Feng, X Yang, MH Gee, KM Jude, ... Science 376 (6589), eabl5282, 2022 | 74 | 2022 |
| Domain-swapped T cell receptors improve the safety of TCR gene therapy MT Bethune, MH Gee, M Bunse, MS Lee, EH Gschweng, MS Pagadala, ... Elife 5, e19095, 2016 | 63 | 2016 |
| Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro MH Gee, LV Sibener, ME Birnbaum, KM Jude, X Yang, RA Fernandes, ... Proceedings of the National Academy of Sciences 115 (31), E7369-E7378, 2018 | 27 | 2018 |
| Identification of antigenic targets HP Gerber, LV Sibener, LJ Lee, MH Gee Trends in cancer 6 (4), 299-318, 2020 | 10 | 2020 |
| Intracellular targets as source for cleaner targets for the treatment of solid tumors HP Gerber, LV Sibener, LJ Lee, M Gee Biochemical pharmacology 168, 275-284, 2019 | 10 | 2019 |
| Facile method for screening clinical T cell receptors for off-target peptide-HLA reactivity MH Gee, X Yang, KC Garcia bioRxiv, 472480, 2018 | 8 | 2018 |
| Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity JL Mendoza, S Fischer, MH Gee, LH Lam, S Brackenridge, FM Powrie, ... Elife 9, e58128, 2020 | 6 | 2020 |
| Domain-swap T cell receptors MT Bethune, MH Gee, D Baltimore US Patent 9,884,075, 2018 | 6 | 2018 |
| Isolation and visualization of a structural trigger that uncouples TCR signaling from pMHC binding LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ... Cell 174 (3), 672, 2018 | 4 | 2018 |
| Computational and Systems Immunology: A Student’s Perspective Z Good, J Glanville, MH Gee, MM Davis, P Khatri Trends in immunology 40 (8), 665-668, 2019 | 3 | 2019 |
| Stabilization of ribozyme-like cis-noncoding rRNAs induces apoptotic and nonapoptotic death in lung cells M Gee, Y Gu, JR Fields, YH Shiao Cell death & disease 3 (3), e281-e281, 2012 | 3 | 2012 |
| Antigen Discovery for T Cell Receptors Isolated from Patient Tumors Recognizing Wild-Type Antigens and Potent Peptide Mimotopes M Gee, MM Davis, A Han, KC Garcia US Patent App. 16/492,898, 2020 | 1 | 2020 |
| Improving anti-tumor immunity by engineering T cell receptors to prevent mispairing (VAC7P. 1033) M Bethune, M Gee, M Lee, M Kuhns, D Baltimore The Journal of Immunology 194 (1_Supplement), 143.3-143.3, 2015 | 1 | 2015 |
| 403 Rapid and multiplexed identification of novel TCRs for TCR-T cell therapy T Moore, B Hegde, J Leonard, N Katz, A Sharathchandra, B Xie, J Dreux, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
